Candidate epitope identification using peptide property models: application to cancer immunotherapy (Q35948346)

11 August 2017

1 reference

title

Candidate epitope identification using peptide property models: application to cancer immunotherapy (English)

1 reference

11 August 2017

1 reference

Myong-Hee Sung

1

1 reference

PubMed ID

15542372

11 August 2017

Richard Simon

series ordinal

2

1 reference

11 August 2017

1 December 2004

1 reference

11 August 2017

1 reference

11 August 2017

34

1 reference

11 August 2017

4

1 reference

11 August 2017

460-467

1 reference

Progress in human tumour immunology and immunotherapy

11 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Isolation of a new melanoma antigen, MART-2, containing a mutated epitope recognized by autologous tumor-infiltrating T lymphocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Overlapping peptides of melanocyte differentiation antigen Melan-A/MART-1 recognized by autologous cytolytic T lymphocytes in association with HLA-B45.1 and HLA-A2.1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

The specificity of TCR/pMHC interaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Genomewide conserved epitope profiles of HIV-1 predicted by biophysical properties of MHC binding peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Predicting class II MHC/peptide multi-level binding with an iterative stepwise discriminant analysis meta-algorithm

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Prediction of well-conserved HIV-1 ligands using a matrix-based algorithm, EpiMatrix.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Quantitative approaches to computational vaccinology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Relating amino acid sequence to phenotype: analysis of peptide-binding data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Prediction of MHC class II-binding peptides using an evolutionary algorithm and artificial neural network.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Prediction of MHC class I binding peptides, using SVMHC

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Tumor-associated antigens identified by mRNA expression profiling induce protective anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Generation of tissue-specific and promiscuous HLA ligand databases using DNA microarrays and virtual HLA class II matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Combinatorial peptide libraries and biometric score matrices permit the quantitative analysis of specific and degenerate interactions between clonotypic TCR and MHC peptide ligands

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

MHCPEP, a database of MHC-binding peptides: update 1997.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Molecular classification of cutaneous malignant melanoma by gene expression profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Identification of p53 peptides recognized by CD8(+) T lymphocytes from patients with bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Immune recognition of cyclin B1 as a tumor antigen is a result of its overexpression in human tumors that is caused by non-functional p53

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Definition of the expression of the human carcinoembryonic antigen and non-specific cross-reacting antigen in human breast and lung carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Differential Anti-MART-1/MelanA CTL Activity in Peripheral Blood of HLA-A2 Melanoma Patients in Comparison to Healthy Donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Definition of MHC-restricted CTL epitopes from non-variable number of tandem repeat sequence of MUC1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Immunization with a HER-2/neu helper peptide vaccine generates HER-2/neu CD8 T-cell immunity in cancer patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Gene expression microarrays: a 21st century tool for directed vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

SYFPEITHI: database for MHC ligands and peptide motifs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

JenPep: a database of quantitative functional peptide data for immunology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

FIMM, a database of functional molecular immunology: update 2002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

Modeling of HLA class II susceptibility to Type I diabetes reveals an effect associated with DPB1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

HLA DPB1*0201 gene confers disease susceptibility in japanese with childhood onset type I diabetes, independent of HLA-DR and DQ genotypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

HLA-DP: a class II restriction molecule involved in epitope spreading during the development of multiple sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

HLA-DR/DQ/DP interactions in rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

T cells discriminate between differentially phosphorylated forms of alphaB-crystallin, a major central nervous system myelin antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

The HLA-A*0201-restricted H-Y antigen contains a posttranslationally modified cysteine that significantly affects T cell recognition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMETH.2004.06.001

10.1016/J.YMETH.2004.06.001

7 January 2021

Identifiers

DOI

1 reference

11 August 2017

1 reference

PubMed ID

15542372